Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell therapy (Aastrom Biosciences Inc).

M A Morse1

  • 1Department of Medicine, Duke University Medical Center, Box 2606, Durham, NC 27710, USA. morse004@mc.duke.edu

Idrugs : the Investigational Drugs Journal
|August 17, 2005
PubMed
Summary

The AastromReplicell System expands hematopoietic stem cells, addressing limitations of traditional bone marrow transplants. This automated system shows promise for generating sufficient cells and reducing tumor contamination for transplantation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nivolumab plus ipilimumab and cobimetinib in previously treated microsatellite-stable/DNA mismatch repair-proficient metastatic colorectal cancer: the phase II CheckMate 142 trial.

ESMO gastrointestinal oncology·2026
Same author

Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIM<sup>SM</sup> registry.

Journal for immunotherapy of cancer·2019
Same author

Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients' preference-based study (PPPS).

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2018
Same author

Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy.

The British journal of dermatology·2018
Same author

X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity.

Cell death & disease·2016

Area of Science:

  • Biotechnology
  • Hematology
  • Cell Biology

Background:

  • Traditional stem cell transplantation relies on large-volume bone marrow or peripheral blood harvests.
  • Existing methods face challenges like insufficient cell numbers and tumor cell contamination.
  • Gene transfer efficiency is limited in non-proliferating cells from these products.

Purpose of the Study:

  • To evaluate the AastromReplicell System for expanding hematopoietic cells.
  • To optimize culture conditions for efficient cell proliferation.
  • To assess the system's potential to overcome limitations in stem cell transplantation.

Main Methods:

  • Utilized a closed, automated system (AastromReplicell) for hematopoietic cell expansion.
  • Investigated optimal growth conditions using unpurified bone marrow/cord blood mononuclear cells.
  • Employed high cell densities, serum-containing medium, and specific plastic surfaces.

Main Results:

  • Demonstrated feasibility of generating sufficient cells from small progenitor volumes for hematopoiesis reconstitution.
  • Observed a passive decrease in tumor cell contamination during the culture period.
  • Identified optimal culture conditions for hematopoietic cell expansion.

Conclusions:

  • The AastromReplicell System offers a potential solution for enhancing stem cell transplantation efficacy.
  • Further direct comparison studies are needed to validate cost-effectiveness and superior outcomes against traditional methods.
  • The system shows promise for improving cell yield and purity in hematopoietic stem cell expansion.

Related Experiment Videos